Fundraising FoxFlagship Pioneering — 2017 Investments
5 investments dated 2017 · listed companies and verified rows first · show all
CIBO provides a software platform for designing, deploying, and measuring regenerative agriculture and conservation programs, including workflow automation, scientific modeling, impact reporting, and a network of advisors managing grower engagement.
AgTechAI & Machine LearningClimate TechSaaSCambridge, US
Bruno Basso(Co-Founder and Special Advisor)David Worn(Executive Officer, Director)inBarry Martin(Executive Officer)inRyan Richt(Executive Officer)inDale Sorensen(Executive Officer)Sunand Menon(Executive Chairman & CEO)in
Board seatIgnacio MartinezStephen BerensonNoubar Afeyan· per SEC Form D
Co-investorsGeneration Investment ManagementStage 1 Ventures
BiotechCambridge, US
Torben Straight Nissen(Executive Officer, Director)inJoanne Protano(Executive Officer)inDavid Epstein(Director)Harvey F. Lodish(Director)Michael Rosenblatt(Director)Roger Pomerantz(Director)in
Board seatNoubar Afeyan· per SEC Form D
Co-investorsFlagship VenturesKendall Capital Partners
Kaleido offers a modular enterprise platform with pre-integrated products for tokenization, custody, digital assets, middleware, interoperability, and blockchain infrastructure.
Crypto & Web3Data & InfrastructureEnterprise Software
Steve Cerveny(Founder)inSophia Lopez(Founder)in
Co-investorsConsenSys MeshValor Capital GroupEQT Life SciencesInnovation IndustriesInvest-NLMenlo Ventures+1 more
Repertoire's Decode platform focuses on mapping the immune synapse — the interactions between T cell receptors, epitopes, and HLA molecules — to support the development of medicines targeting cancer and other diseases.
AI & Machine LearningBiotechDeep TechDigital HealthHealthtech
Torben Straight Nissen(Chief Executive Officer)inAnthony Coyle(President, Research and Development)inRobert Andtbacka(Chief Medical Officer)inJohn Delyani(Chief Business Officer)inJan Kisielow(Chief Scientific Officer, Repertoire Immune Medicines (Switzerland) Ltd.)in
Co-investorsSoftBank Vision FundJDRF T1D Fund
Other
Tracked investments with no reachable website or further public details — typically companies that wound down, renamed, or were absorbed.
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.